Last active: 11/28/2017


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction. Hill MF, Patel AV, Murphy A, Smith HM, Galindo CL, Pentassuglia L, Peng X, Lenneman CG, Odiete O, Friedman DB, Kronenberg MW, Zheng S, Zhao Z, Song Y, Harrell FE, Srinivas M, Ganguly A, Iaci J, Parry TJ, Caggiano AO, Sawyer DB (2013) PLoS One 8(2): e55741
    › Primary publication · 23437060 (PubMed) · PMC3578842 (PubMed Central)
  2. Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort. Geisberg CA, Abdallah WM, da Silva M, Silverstein C, Smith HM, Abramson V, Mayer I, Means-Powell J, Freehardt D, White B, Lenihan D, Sawyer DB (2013) J Card Fail 19(1): 10-5
    › Primary publication · 23273589 (PubMed) · PMC3562720 (PubMed Central)
  3. Circulating vascular growth factors and central hemodynamic load in the community. Zachariah JP, Xanthakis V, Larson MG, Vita JA, Sullivan LM, Smith HM, Safa R, Peng X, Hamburg N, Levy D, Sawyer DB, Mitchell GF, Vasan RS (2012) Hypertension 59(4): 773-9
    › Primary publication · 22371357 (PubMed) · PMC3336212 (PubMed Central)
  4. Relation of vascular growth factors with CT-derived measures of body fat distribution: the Framingham Heart Study. Kaess BM, Pedley A, Massaro JM, Larson MG, Corsini E, Hoffmann U, Smith HM, Sawyer DB, Vasan RS, Fox CS (2012) J Clin Endocrinol Metab 97(3): 987-94
    › Primary publication · 22170711 (PubMed) · PMC3319207 (PubMed Central)
  5. Circulating neuregulin-1β levels vary according to the angiographic severity of coronary artery disease and ischemia. Geisberg CA, Wang G, Safa RN, Smith HM, Anderson B, Peng XY, Veerkamp B, Zhao DX, Blakemore D, Yu C, Sawyer DB (2011) Coron Artery Dis 22(8): 577-82
    › Primary publication · 22027878 (PubMed) · PMC3217257 (PubMed Central)
  6. Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community. Lieb W, Zachariah JP, Xanthakis V, Safa R, Chen MH, Sullivan LM, Larson MG, Smith HM, Yang Q, Mitchell GF, Vita JA, Sawyer DB, Vasan RS (2010) Circ Cardiovasc Genet 3(3): 300-6
    › Primary publication · 20348331 (PubMed) · PMC2892960 (PubMed Central)
  7. Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function. Lieb W, Safa R, Benjamin EJ, Xanthakis V, Yin X, Sullivan LM, Larson MG, Smith HM, Vita JA, Mitchell GF, Sawyer DB, Vasan RS (2009) Eur Heart J 30(9): 1121-7
    › Primary publication · 19223316 (PubMed) · PMC2721714 (PubMed Central)
  8. Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione. Hamblin M, Smith HM, Hill MF (2007) J Card Fail 13(10): 884-92
    › Primary publication · 18068623 (PubMed) · PMC2685187 (PubMed Central)
  9. Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy. Hamblin M, Friedman DB, Hill S, Caprioli RM, Smith HM, Hill MF (2007) J Mol Cell Cardiol 42(4): 884-95
    › Primary publication · 17320100 (PubMed) · PMC2677446 (PubMed Central)
  10. Greater propensity of diabetic myocardium for oxidative stress after myocardial infarction is associated with the development of heart failure. Smith HM, Hamblin M, Hill MF (2005) J Mol Cell Cardiol 39(4): 657-65
    › Primary publication · 16125723 (PubMed)
  11. Ethanol-induced mitogen activated protein kinase activity mediated through protein kinase C. Washington B, Mtshali C, Williams S, Smith H, Li JD, Shaw B, Gwathmey J (2003) Cell Mol Biol (Noisy-le-grand) 49(8): 1351-6
    › Primary publication · 14984009 (PubMed)
  12. Effect of ergotamine and ergonovine on plasma concentrations of thyroid hormones and cortisol in cattle. Browning R, Leite-Browning ML, Smith HM, Wakefield T (1998) J Anim Sci 76(6): 1644-50
    › Primary publication · 9655585 (PubMed)
  13. Plasma concentrations of prolactin, growth hormone, and luteinizing hormone in steers administered ergotamine or ergonovine. Browning R, Thompson FN, Sartin JL, Leite-Browning ML (1997) J Anim Sci 75(3): 796-802
    › Primary publication · 9078499 (PubMed)
  14. Effect of ergotamine and ergonovine on thermal regulation and cardiovascular function in cattle. Browning R, Leite-Browning ML (1997) J Anim Sci 75(1): 176-81
    › Primary publication · 9027563 (PubMed)

Featured Affiliation

No featured affiliations

    View all affiliations

    Contact Information

    PRB 359
    359 Preston Research Building
    Nashville, TN 37232
    6159361916 (p)
    6159361872 (f)

    Show more

    Keywords & MeSH Terms

    MeSH terms are retrieved from PubMed records. Learn more.

    Key: MeSH Term Keyword

    Angiopoietin-2 Animals Anthracyclines Aorta Cardiac Output, Low Cardiomyopathies Cardiovascular System Cross-Over Studies Diet Dietary Supplements Genetic Linkage Growth Hormone Heart Failure Heart Rate Hemodynamics Insulin-Like Growth Factor Binding Protein 3 Insulin-Like Growth Factor I Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinases Obesity Predictive Value of Tests Prognosis Prolactin Protein Kinase C Receptors, Vascular Endothelial Growth Factor Risk Factors Severity of Illness Index Treatment Outcome Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factor Receptor-1